Comprehensive analysis of RET and ROS1 rearrangement in lung adenocarcinoma
Comprehensive analysis of RET and ROS1 rearrangement in lung adenocarcinoma
About this item
Full title
Author / Creator
Publisher
New York: Nature Publishing Group US
Journal title
Language
English
Formats
Publication information
Publisher
New York: Nature Publishing Group US
Subjects
More information
Scope and Contents
Contents
The success of crizotinib in
ALK
-positive patients has elicited efforts to find new oncogenic fusions in lung cancer. These efforts have led to the discovery of novel oncogenic fusion genes such as
ROS1
and
RET
. However, the molecular and clinicopathologic characteristics associated with
RET
or
ROS1
fusion, compared...
Alternative Titles
Full title
Comprehensive analysis of RET and ROS1 rearrangement in lung adenocarcinoma
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_1669832782
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1669832782
Other Identifiers
ISSN
0893-3952
E-ISSN
1530-0285
DOI
10.1038/modpathol.2014.107
